Dräger Medical Receives FDA Clearance for Automated Weaning Options for EvitaXL Ventilator

AARC Corporate Partner, Dräger Medical, Inc., recently announced its SmartCare/PS options for the EvitaXL ventilator have received market clearance for additional product claims from the FDA.

SmartCare is a knowledge-based ventilation system developed to improve the efficiency and effectiveness of the weaning process for hemo-dynamically and neurologically stable patients without severe COPD.

Dräger Medical, Inc. joined the AARC Corporate Partner Program in 2007. The AARC's Corporate Partner Program is comprised of best-in-class organizations interested in supporting the goals and work of the Association.